RAB32 and neoplasm: The model includes seven key genes—SNX5, YBX1, GNPD1, RAB32, TPM3, ATP6V0B, and RAB7A—which may be involved in tumor growth, immune escape, and microenvironment remodeling and may serve as potential targets for therapy.